Scientists probe if diabetes drug changes what you crave
NCT ID NCT02674893
Summary
This study aimed to understand how the diabetes medication liraglutide (Victoza®) changes eating behavior in people with type 2 diabetes. Researchers compared three groups: patients starting the drug, similar patients not on the drug, and healthy volunteers. They measured changes in food cravings, taste preferences, and salivation over several months to learn more about the drug's effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de DIJON
Dijon, 21079, France
Conditions
Explore the condition pages connected to this study.